ArticleNature communications2026
StrucGAP: a modular, streamlined and traceable data mining platform for structural and site-specific glycoproteomics.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The rapidly developing search engines for glycopeptide identification and accumulated high-resolution glycoproteomic data underscore the need for robust downstream data mining platforms towards subsequently functional and mechanistic studies. Here, we introduce StrucGAP, a Structural Glycoproteomics Analysis Platform for scalable downstream data mining of site-specific N-glycoproteomics. It integrates modules for data quality control, overall glycan structural characterization, altered glycan feature extraction, functional annotation, as well as upstream regulation and downstream networks. Its visualization and insight-tracking functionalities distill interpretation across hundreds of outputs, uniquely enabling to generate chart-based analysis reports and extract key glycosylation insights-capabilities rarely found in existing omics tools. Applying StrucGAP to an uncharacterized aging mouse uterus dataset reveals bidirectional regulation of core-fucosylation, and progressive, coordinated enrichment of glycans featuring sialylation via Neu5Ac, Lewis epitopes, and hybrid glycans along glycosylation dynamics. These changes are functionally linked to adhesion and remodeling, demonstrating StrucGAP's ability to distill critical glycosylation insights from multi-dimensional information of structural N-glycoproteome datasets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.